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Summary.-A single intravenous injection of 100 mg/kg body weight (b.w.) of 7, 12
dimethylbenz(a)anthracene (DMBA) induces a high percentage of ovarian granulosa
cell tumours in C3H mice. After implantation of ovarian tissue into the spleen of
gonadectomized female C3H mice similar tumours were found, resulting from an
over-stimulation by pituitary gonadotrophins. In the present study the tumour
development in intrasplenic ovarian tissue was observed after an additional single
intravenous application of 100 mg/kg b.w. DMBA. It was found that the induction of
granulosa cell tumours did not seem to be affected by the carcinogen injection
whether 12 weeks before or 12 weeks after ovarian tissue was implanted into the
spleen. The morphology of these neoplasms corresponds to the DMBA induced
granulosa cell tumours in orthotopic ovaries. A direct carcinogenic effect of DMBA
on ovarian cells in mice could not be demonstrated but there are indications that the
additional DMBA application accelerated the destruction ofthe oocytes, which might
result in a more rapid intrasplenic tumour induction.
OVARIAN tissue was found to develop plication but that implantation of ovarian
benign granulosa or granulosa-theca cell tissue into the spleen, followed by intra-
tumours after implantation into the spleen venous DMBA treatment, resulted in the
of gonadectomized rats (Biskind and transformation from benign to malignant
Biskind, 1944). This is due to an unin- granulosa, a few cases of theca cell
hibited stimulation of pituitary gland tumours, and a single androblastoma-like
gonadotrophins (Heller and Jungck, 1947; neoplasm. It has been suggested that the
Miller and Pfeiffer, 1950; Achilles and change in hormonal balance through the
Sturgis, 1951; Lipschutz, Cerisola and implantation ofovarian tissue presupposes
Panasevich, 1964)becausesteroidssecreted the necessary conditions for the carcino-
from the implant pass directly through the genic effect of DMBA.
portal system to the liver where they are In contrast to rats, normal mice
inactivated (Golden and Sevringhaus, developed granulosa cell tumours of the
1938; Lipschutz et al., 1964; Leavitt, ovary after the administration of DMBA
Carlson and Meyer, 1971) and therefore (Howell, Marchant and Orr, 1954; Mar-
the feedback mechanism betweenpituitary chant, 1957; Mody, 1960; Biancifiori,
gland and ovarian tissue is interrupted. Bonser and Caschera, 1961; Kuwahara,
Preliminary inVestigations (Hilfrich 1967; Krarup, 1970a).
and Mohr, 1973; Hilfrich, 1973, 1974) have As gonadectomy with implantation of
shown that in rats normal, non-implanted ovarian tissue into the spleen of female
ovarian tissue is not affected by 7, 12 mice also leads to the development of
dimethylbenz(a)anthracene (DMBA) ap- granulosa cell tumours (Furth and Sobel,
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1947; Gardner, 1955; Guthrie, 1957), the 10 ml solvent/kg b.w. (controls); (4) 30
present study was undertaken to compare mice given 100 mg DMBA/kg b.w., 12 weeks
the influence of DMBA on tumour devel- before implantation of ovarian tissue into the
opment in implanted ovarian tissue in spleen; (5) 20 mice, 12 weeks after implanta-
mice with that in rats. tion of ovarian tissue into the spleen, given
100 mg DMBA/kg b.w.
Dead animals were autopsied and all
MATERIALS AND METHODS organs fixed in 4% buffered formali4;
Ninety female, 3-month old C3H mice paraplast sections were stained with haema-
(Laboratory Animals Breeding and Research toxylin and eosin and van Gieson stain; the
Centre, Bomholtg&rd, Denmark) of 25-30 g ovarian tumours were also stained with PAS
body weight (b.w.) were kept in groups of 3 and Alcian blue, Gomori, Masson-Goldner
in Makrolon cages Type II (E. Becker & and Sudan III. The effective number of
Co., GMBH, Castrop-Rauxel, FRG) under animals is based on the number of mice
standard laboratory conditions (room tem- surviving after the first tumour of any site
perature 22 : 2°C; relative humidity had been observed. A few mice were lost
55 ± 5%; air exchange 8 times/h), with through cannibalism or the adverse effects of
Hope Farms RMH-TMB pelleted diet the surgical operation.
(Woerden, The Netherlands) and water ad For statistical comparison of intrasplenic
libitum. Sixty mice were ovariectomized ovarian tumour incidence, the chi-square
under ether anaesthesia (Pronarcosi, Hoechst test, and for the average survival times, the
AG, Frankfurt, FRG), and a piece of ovary U-test after Mann and Whitney (1947) were
1-2 mm in diameter was implanted into the performed.
spleen according to the method described by
Biskind and Biskind (1949). The animals
received a single intravenous injection of
100 mg DMBA (special 15% fat emulsion Table I summarizes the average
with 7,12-dimethylbenz(a)anthracene 5 mg/ survival rates as well as the incidence of
g; The Upjohn Company, Kalamazoo, Michi- ovarian and other tumours in Groups 1
gan, USA) per kg b.w. or 10 ml/kg b.w. ofthe and 2 (orthotopic ovaries). In control
solvent (intravenous fat emulsion without animals no ovarian tumours were found;
dextrose; The Upjohn Company, Kalamazoo, however, after treatment with a single Michigan, USA). dose of DMBA 7 o th a showe Treatment groups.-These consisted of dose of DMBA 78.9% of the mice showed
(1) 10 mice given 10 ml solvent/kg b.w. an ovarian tumour, in one animal bi-
(controls); (2) 20 mice given 100 mg DMBA/ laterally (Fig. 1). The first neoplasm of
kg b.w.; (3) 10 mice, 12 weeks afterimplanta- the ovary was observed 29 weeks after
tion of ovarian tissue into the spleen, given DMBA application. Macroscopically,
TABLE I.-Ovarian and Other Tumour Incidence in Female C3H Mice after DMBA
Treatment
Animals with
Average survival,____________ ____
No. of after treatment Ovarian
Treatment animals in weeks tumours -v
groups initial/effect. (range) - (%) Tumours,,of other sites (no.) Leukaemias
1 10/10 81-9 (52-.123) - Malignant lymphoma (1)
(control)
2 20/19 55-5 (27-84) 15 (78.9) Angiosarcoma (2) and stromal 11
(DMBA) sarcoma (2) of uterus
Papilloma or squamous cell
carcinoma of forestomach (3)
- Fibrovascular polyp (1) and
squamous cell carcinoma
of vagina (2)
Adenoma of lung (2)
Adenocarcinoma of mammary
gland (1)590 J. HILFRICH
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FIa. 2. Intrasplenic granulosa cell tumour with grepwhite tumour masses, haemorrhages and
necroses, 99 weeks after DMBA treatment and 87 weeks after implantation of ovarian tissue into
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TABLE II.-Ovarian and Other Tumour Incidence in Gonadectomized Female C3H Mice
after Implantation of Ovarian Tissue into the Spleen and DMBA Treatment
Intrasplenic
No. of Average survival granulosa
Treatment animals after ovarian cell
groups initial/ implant. in tumours* Animals with tumours
effect. weeks (range) (%) of other sites (no.) Leukaemias
3 10/10 85 0 (38-124) 5 (50-0) Malignant lymphoma (2)
(control, Carcinoma of adrenal gland
intraspl. cortex (2)
ov.) Fibrosarcoma of mediastinum (1)
Fibrovascular polyp of cervix (1)
4 30/24 49- 8 (11-92) 8 (33 3) Papilloma or squamous cell 9
(DMBA, carcinoma of forestomach (10)
intraspl. Adenoma or adenocarcinoma of
ov.) lung (7)
Adenocarcinoma of mammary
gland (4)
Adenoma or carcinoma of adrenal
gland cortex (4)
Stromal sarcoma (1), haemangioma
(1) and fibrovascular polyp (1)
of uterus
Retroperitoneal neuroblastoma (1)
Keratoacanthoma of skin (1)
Hepatoma (1)
5 20/16 56-4 (29-82) 7 (43 8) Papilloma or squamous cell 6
(intraspl. carcinoma of forestomach (4)
ov., Adenoma of lung (3)
DMBA) Adenocarcinoma of mammary
gland (1)
Malignant thymoma (1)
Squamous cell carcinoma of
vagina (1)
Adenoma of adrenal gland
cortex (1)
Hepatoma (1)
* Pre-neoplastic stages are not included.
these neoplasms were up to 25 mm in with blood filled cysts, haemorrhages and
diameter with grey-white tumour masses, necroses in larger neoplasms (Fig. 2).
and most also exhibited extensive haem- These observations were comparable with
orrhages and necroses. In one case lung those detected in tumours of orthotopic
metastases were found. In the carcinogen ovaries. Liver metastases were found, one
treated Group 2 a large number of mice case each in Groups 3 and 4, and 2 in
with leukaemias, as well as neoplasms Group 5.
other than the ovary, were detected; The induced ovarian tumours demon-
these were mainly of the uterus, fore- strated similar morphological patterns,
stomach, vagina and lung (Table I). not only in orthotopic ovaries (Group 2)
Table II lists the average survival but also (with or without the carcinogen
rates as well as the number of animals application) in implanted tissue (Groups
with ovarian tumours in the spleen and 3-5). In all cases granulosacelltumours
those with other neoplasms occurring in were found, with clusters and cords or
Groups 3, 4 and 5. All these 3 groups parenchymatous growth ofgranulosa cells;
demonstrated neoplastic growths in the luteinized theca cells and fibre formation
spleen that ranged in size from small were present only sparsely (Fig. 3).
nodules only a few mm in diameter to Follicular structures of varying sizes were
tumours of up to 40 mm. Upon cut also seen, the larger frequently being
section yellowish or predominantly grey- blood filled (Fig. 4). Furthermore, tubular
white tumour masses were seen, together adenoid formations (Fig. 5) and highly
41592 J. HILFRICH
~. V * $~, At IN
I A X * t4m'.-
~~~ 'ft~~4~S A
f f lU~~~~~~~~~~~~~U
47~~~~~~~~~~~4
FiG. 3.-Granulosa cell tumour (orthotopic ovary) with different sized clusters of granulosa cells,
separated by narrow but distinct fibrous septa. H. and E. x 300.
4, 0~~~~~~~~~~~~~~~~
FiG. 4.-Granulosa cell tumour (orthotopic ovary) with follicular structures, the larger blood filled
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FiG. 5.-Tubular adenoid formations as well as luteinized stromal (theca) cells in an intrasplenic
granulosa cell tumour. H. and E. x 350.
V., Wr2
4
FiG. 6.-Extensive luteinized area and tubular adenoid structures as well as foci of granulosa cell
proliferations originated in intrasplenic ovarian tissue. H. and E. x 300.594 J. HILFRICH
luteinized areas (Fig. 6) resembling (when genic effect of DMBA on mouse ovaries is
extensive) a luteoma were detected; these related to the immediate destruction of
morphological alterations mostly preceded small oocytes, whereas the prolonged
the described granulosa cell proliferations. retention of DMBA after intraperitoneal
In the granulosa cell tumours numerous injection is ofno significance for neoplastic
mitoses and infiltrative growth could be development.
observed, inadditionto necrosesandhaem- Further, the induction of granulosa
orrhages in the more extensive neo- cell tumours in intrasplenic ovarian im-
plasms. plants of mice (Furth and Sobel, 1947;
In the DMBA treated Groups 4 and 5 Gardner, 1955; Guthrie, 1957) and by
the average survival time after implanta- x-ray irradiation (Furth and Butterworth,
tion of ovarian tissue into the spleen was 1936; Lick, Kirschbaum and Mixer, 1949;
significantly lower (P < 0.01, P < 0 05 Kaplan, 1950; Guthrie, 1958) preceded
respectively) than in the control Group 3 the destruction of the oocytes. The
(Table II). Furthermore, the survival developed ovarian tumours in all the
time of intrasplenic granulosa cell tumour aforementioned induction methods were
bearing animals was significantly similar and of granulosa cell origin.
shortened in Groups 4 and 5 (P = 0.005) Therefore, the authors assumed that the
compared with Group 3. However, there over-stimulation by pituitary gonadotro-
was no statistically significant difference phins might be decisive for the tumour
(0 9 > P > 0 8) in the incidenceofovarian induction, not only in intrasplenic ovarian
tumours in the spleen (Table II) among implants but also in degeneratively
untreated mice (Group 3), the mice changed ovaries after DMBA treatment or
treated with DMBA 12 weeks before irradiation because these gonads lose
(Group 4), or 12 weeks after (Group 5) the ability to produce sufficient steroids
implantation of ovarian tissue into the to control the output of gonadotrophic
spleen. hormones. The retention of a normal
functioning ovary (Marchant, 1960; Jull,
DISCUSSION 1969), hypophysectomy (Marchant, 1961)
The present study has shown that the or the application ofan antigonadotrophic
development of granulosa cell tumours serum (Ely, 1959) prevented the ovarian
after implantation of ovarian tissue into tumour development.
the spleen of C3H mice is not affected by The results of the present study
additional DMBA application; the mor- confirm the hormone theory of ovarian
phology ofthese neoplasms corresponds to tumour induction in mice after application
the DMBA induced granulosa cell tumours of DMBA; in contrast to rats, mice
in orthotopic ovaries. Similar findings demonstrate no direct carcinogenic effect
were described by Li, Gardner and Kaplan of DMBA on ovarian cells, even under the
(1947) when they used x-ray irradiated conditions ofimplantation into the spleen.
ovaries for intrasplenic implantation. Since in the DMBA treated Groups 4 and 5
Howell et al. (1954) reported the induction the survival time ofintrasplenic granulosa
of granulosa cell tumours in orthotopic cell tumour bearing animals was signi-
ovaries ofmice afterrepeated skinpainting ficantly lower compared with control mice
with DMBA. Marchant (1957), Mody (Group 3), it is possible that the additional
(1960) as well as Krarup (1969, 1970a,b) DMBAapplicationacceleratedthe destruc-
could show that DMBA application to tion ofthe oocytes, which might result in a
mice led to a rapid destruction mainly of more rapid intrasplenic tumour induction.
the small oocytes which, therefore, seem to
be the primary target cells of DMBA in
the ovaries ofmice. Furthermore, Krarup I am grateful to Christine Murphy for
and Loft (1971) observed that the carcino- assisting with the manuscript.MORPHOLOGICAL STUDIES ON THE CARCINOGENIC EFFECT 595
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